Nicola Ga-Ling Eastaff-Leung

Title: Nicola Ga-Ling Eastaff-Leung: Innovator in Protein Research

Introduction

Nicola Ga-Ling Eastaff-Leung is a notable inventor based in Blackwood, Australia. He has made significant contributions to the field of protein research, particularly in the development of proteins that bind to peptidase inhibitor 16 (PI16). His innovative work has implications for diagnosis and therapy, showcasing the potential of his inventions in medical applications.

Latest Patents

Nicola holds a patent for "Proteins that bind PI16 and uses thereof." This patent describes an isolated protein that includes at least one antibody variable region capable of binding to PI16. The protein is designed to competitively inhibit the binding of an antibody produced by a specific hybridoma to PI16. The invention also outlines various uses for the protein, including its application in diagnosis, therapy, and the isolation of Treg cells.

Career Highlights

Nicola is currently associated with Medvet Science Pty Ltd, where he continues to advance his research in protein technology. His work is characterized by a commitment to innovation and a focus on practical applications that can benefit healthcare.

Collaborations

Some of Nicola's coworkers include Simon Barry and Doreen Krumbiegel, who contribute to the collaborative environment at Medvet Science Pty Ltd. Their combined expertise fosters a dynamic research atmosphere that enhances the development of new technologies.

Conclusion

Nicola Ga-Ling Eastaff-Leung is a pioneering inventor whose work in protein research holds promise for advancements in medical science. His contributions, particularly in the area of PI16 binding proteins, reflect a dedication to innovation and collaboration in the field.